Current NDC auxiliary source row compounder:4041

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 69194-148
Product Ndc: 69194-148
Product Ndc Digits: 69194148
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: DEUTERIUM OXIDE REPACKAGED ORAL
Proprietary Name Suffix: [empty]
Nonproprietary Name: DEUTERIUM OXIDE D 70
Dosage Form Name: SOLUTION
Route Name: ORAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Pine Pharmaceuticals LLC
Establishment Name: Pine Pharmaceuticals LLC
Establishment Fei: [empty]
Substance Name: DEUTERIUM OXIDE
Active Ingredients Info: [empty]
History Active Ingredients Raw: DEUTERIUM OXIDE
History Active Ingredients Info Raw: [empty]
History Dosage Raw: SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 69194-148-01
Package Ndc: 69194-148-01
Package Ndc Digits: 6919414801
Package Ndc11: 69194014801
Package Description: 50 mL in 1 VIAL (69194-148-01)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4041
Source Row Number: 4041
Source Row Hash: d550f742f813da8307eb773368e57c8ccf2e7242c9901f8a85cd042b39559a95
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "ORAL",
    "PRODUCTNDC": "69194-148",
    "DEASCHEDULE": "",
    "LABELERNAME": "Pine Pharmaceuticals LLC",
    "SUBSTANCENAME": "DEUTERIUM OXIDE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "69194-148-01",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "DEUTERIUM OXIDE REPACKAGED ORAL",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "DEUTERIUM OXIDE D 70",
    "PACKAGEDESCRIPTION": "50 mL in 1 VIAL (69194-148-01) ",
    "ACTIVEINGREDIENTSINFO": "",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4041
Source Row Number: 4041
Status Scope: package
Lookup Ndc: 69194-148-01
Lookup Ndc Digits: 6919414801
Product Ndc: 69194-148
Product Ndc Digits: 69194148
Package Ndc: 69194-148-01
Package Ndc Digits: 6919414801
Package Ndc11: 69194014801
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: d550f742f813da8307eb773368e57c8ccf2e7242c9901f8a85cd042b39559a95
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33